HIVR4P is the world’s first and only scientific meeting dedicated exclusively to biomedical HIV prevention research, including ARV-based prevention (treatment as prevention, microbicides, and pre-exposure prophylaxis (PrEP)); vaccines; circumcision; and related areas of HIV prevention.
HIVR4P is the premier global and scientific conference focused on HIV prevention research. The conference program includes abstract and non-abstract driven oral and poster sessions on the latest research in HIV prevention science, high-level plenaries addressing the big-picture issues confronting the field, symposia, debates, roundtables, and satellite sessions.
HIVR4P is chaired by four preeminent researchers in their fields: Tom Hope of Northwestern University, USA; Jeanne Marrazzo of the University of Washington, USA; Lynn Morris of the National Institute for Communicable Diseases, South Africa; and Nelly Mugo of the Kenya Medical Research Institute. The conference Program Organizing Committee includes approximately 40 members reflecting different areas of biomedical prevention research, and geography, gender, and career stage.
More than 1,300 researchers, advocates, clinicians, policy makers, private sector partners, and public health experts presented and debated the latest HIV prevention research at the first HIVR4P conference in Cape Town. We expect a similar number of leaders in the field to attend HIVR4P 2018 in Madrid, Spain.
Community involvement will be central to the meeting. The conference organizers are fundraising to support a large number of scholarships, and will ensure the participation of low- and middle-income country representatives and early-career investigators at the conference.
The search for effective biomedical HIV prevention options has progressed further and changed faster in the last few years than at any time since the epidemic began. HIVR4P responds to a growing consensus that effective HIV prevention will require a combination of approaches and unprecedented collaboration between fields of research.
HIVR4P will build on and link to the successes of the past biennial microbicide and annual vaccine conferences. This new global conference creates opportunities for cross-fertilization among all areas of HIV prevention research, while also providing a venue to discuss research findings, questions, and priorities that are specific to each.